TABLE 1

Licensed Meningococcal Vaccines: United States, 1981–2013

FormulationTypeTrade NameManufacturerLicensed (y)Age GroupDose(s)Serogroups
MPSV4aPolysaccharideMenomuneSanofi Pasteur1981≥2 ySingle doseA, C, W, and Y
MenACWY-DbConjugateMenactraSanofi Pasteur200511 to 55 ySingle doseA, C, W, and Y
MenACWY-DbConjugateMenactraSanofi Pasteur20072 to 10 ySingle doseA, C, W, and Y
MenACWY-DbConjugateMenactraSanofi Pasteur20119 to 23 mo2-dose seriesA, C, W, and Y
MenACWY-CRMcConjugateMenveoNovartis201011 to 55 ySingle doseA, C, W, and Y
MenACWY-CRMcConjugateMenveoNovartis20112 to 10 ySingle doseA, C, W, and Y
MenACWY-CRMcConjugateMenveoNovartis20132 mo to 2 y4-dose seriesA, C, W, and Y
Hib-MenCY-TTdConjugateMenHibrixGlaxoSmithKline20126 wk to 18 mo4-dose seriesC and Y